Morgan Stanley’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-79
| Closed | -$380 | – | 8072 |
|
|
2023
Q3 | $380 | Hold |
79
| – | – | ﹤0.01% | 7336 |
|
|
2023
Q2 | $307 | Hold |
79
| – | – | ﹤0.01% | 7420 |
|
|
2023
Q1 | $198 | Sell |
79
-1
| -1% | -$3 | ﹤0.01% | 7518 |
|
|
2022
Q4 | $146 | Buy |
80
+1
| +1% | +$2 | ﹤0.01% | 7670 |
|
|
2022
Q3 | $1K | Sell |
79
-1
| -1% | -$13 | ﹤0.01% | 7656 |
|
|
2022
Q2 | $1K | Sell |
80
-61
| -43% | -$763 | ﹤0.01% | 7750 |
|
|
2022
Q1 | $3K | Buy |
141
+49
| +53% | +$1.04K | ﹤0.01% | 7711 |
|
|
2021
Q4 | $2K | Buy |
92
+72
| +360% | +$1.57K | ﹤0.01% | 7834 |
|
|
2021
Q3 | $1K | Sell |
20
-484
| -96% | -$24.2K | ﹤0.01% | 7876 |
|
|
2021
Q2 | $39K | Buy |
504
+461
| +1,072% | +$35.7K | ﹤0.01% | 6775 |
|
|
2021
Q1 | $5K | Sell |
43
-765
| -95% | -$89K | ﹤0.01% | 7132 |
|
|
2020
Q4 | $129K | Buy |
808
+737
| +1,038% | +$118K | ﹤0.01% | 5807 |
|
|
2020
Q3 | $8K | Sell |
71
-1,803
| -96% | -$203K | ﹤0.01% | 6347 |
|
|
2020
Q2 | $227K | Buy |
1,874
+5
| +0.3% | +$606 | ﹤0.01% | 5019 |
|
|
2020
Q1 | $147K | Sell |
1,869
-2,315
| -55% | -$182K | ﹤0.01% | 5014 |
|
|
2019
Q4 | $1.23M | Buy |
4,184
+2,334
| +126% | +$687K | ﹤0.01% | 4392 |
|
|
2019
Q3 | $334K | Buy |
1,850
+223
| +14% | +$40.3K | ﹤0.01% | 4876 |
|
|
2019
Q2 | $649K | Buy |
1,627
+1,542
| +1,814% | +$615K | ﹤0.01% | 4461 |
|
|
2019
Q1 | $40K | Sell |
85
-774
| -90% | -$364K | ﹤0.01% | 5764 |
|
|
2018
Q4 | $413K | Sell |
859
-47
| -5% | -$22.6K | ﹤0.01% | 4902 |
|
|
2018
Q3 | $617K | Sell |
906
-243
| -21% | -$165K | ﹤0.01% | 4875 |
|
|
2018
Q2 | $785K | Buy |
+1,149
| New | +$785K | ﹤0.01% | 4782 |
|